Skip to main content

R Nallangi

First name:
R
Last name:
Nallangi
Samala, G. ., Nallangi, R. ., Devi, P. ., Saxena, S. ., Yadav, R. ., Sridevi, J. ., … Sriram, D. . (2014). Identification and development of 2-methylimidazo 1,2-a pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 22(15), 4223-32. https://doi.org/10.1016/j.bmc.2014.05.038 (Original work published 2014)
Samala, G. ., Kakan, S. ., Nallangi, R. ., Devi, P. ., Sridevi, J. ., Saxena, S. ., … Sriram, D. . (2014). Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione CD59 . International Journal of Mycobacteriology, 3(2), 117-26. https://doi.org/10.1016/j.ijmyco.2014.02.006
Samala, G. ., Devi, P. ., Nallangi, R. ., Sridevi, J. ., Saxena, S. ., Yogeeswari, P. ., & Sriram, D. . (2014). Development of novel tetrahydrothieno 2,3-c pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. Bioorganic & Medicinal Chemistry, 22(6), 1938-47. https://doi.org/10.1016/j.bmc.2014.01.030 (Original work published 2014)